AHA Coding Clinic® for ICD-10-CM and ICD-10-PCS - 2025 Issue 3; Ask the Editor
Administration of Prophylactic Monoclonal Antibodies for Respiratory Syncytial Virus (RSV)
What is the ICD-10-PCS procedure code assignment for the intramuscular administration of prophylactic long-acting monoclonal antibodies, such as Nirsevimab-alip (Beyfortus™), for RSV? Would the correct code assignment be XW023Y7, Introduction of other new technology monoclonal antibody into muscle, percutaneous approach, new technology group 7? ...
Subscribe or sign in to view the full article.
Article Overview
This premium article focuses on ICD-10-PCS procedure code assignment for intramuscular administration of prophylactic long-acting monoclonal antibodies for RSV prevention. It is intended for inpatient coding professionals, CDI staff, and billers who need to understand the applicable procedure coding approach and the related coding option discussed in the article. The content centers on how the topic is framed for code assignment and on the general considerations facilities may use when documenting this type of administration.
Why This Topic Matters
RSV prevention products and their administration can affect inpatient procedure coding, documentation, and code selection workflows. Understanding the article helps coders identify the relevant ICD-10-PCS context for this medication administration scenario.
What You Will Learn
- How the article frames ICD-10-PCS coding for RSV monoclonal antibody administration.
- The general procedure coding context discussed for intramuscular administration of prophylactic monoclonal antibodies.
- What coding options are mentioned for facility use in this scenario.
- How the topic relates to inpatient coding and documentation review.
Who Should Read This
- Inpatient medical coders
- Coding auditors
- CDI professionals
- Health information management staff
- Revenue cycle teams
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com